Volume 70, Issue 5 pp. 775-781
Original Article

Clinicopathological significance of a solid component in papillary thyroid carcinoma

Ryuji Ohashi

Corresponding Author

Ryuji Ohashi

Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan

Address for correspondence: R Ohashi, Department of Diagnostic Pathology, Nippon Medical School Hospital, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan. e-mail: [email protected]Search for more papers by this author
Kiyoko Kawahara

Kiyoko Kawahara

Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan

Search for more papers by this author
Shigeki Namimatsu

Shigeki Namimatsu

Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan

Search for more papers by this author
Takehito Igarashi

Takehito Igarashi

Department of Endocrine Surgery, Nippon Medical School Hospital, Tokyo, Japan

Search for more papers by this author
Takashi Sakatani

Takashi Sakatani

Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan

Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan

Search for more papers by this author
Iwao Sugitani

Iwao Sugitani

Department of Endocrine Surgery, Nippon Medical School Hospital, Tokyo, Japan

Search for more papers by this author
Zenya Naito

Zenya Naito

Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan

Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan

Search for more papers by this author
First published: 24 November 2016
Citations: 25

Abstract

Aims

Solid variant of papillary thyroid carcinoma (SVPTC) is characterized by a solid component (SC) involving more than 50% of the tumour with the preservation of the classical cytological features of papillary thyroid carcinoma (PTC). However, the clinical significance of SC in PTC has been rarely examined. Herein, we investigated retrospectively the clinicopathological features of PTC with various degrees (10–85%) of SC (PTCSC).

Methods and results

Patients with PTCSC (n = 27) were stratified into SC-major (SC > 50% of the tumour) and SC-minor (SC < 49%) groups. The clinicopathological parameters were compared to the well-differentiated PTC (WPTC) group (n = 47). Both SC-minor (n = 18) and SC-major (n = 9) groups had increased incidence of a large-sized tumour, extracapsular extension and a high recurrence rate, compared to WPTC. Disease-free survival (DFS) of both SC-minor and SC-major was shorter than that of WPTC (P = 0.035 and P = 0.016, respectively). Overall survival was similar among all the groups. Univariate analysis revealed that SC was associated significantly with a recurrence rate (P = 0.018). Using multivariate analysis, SC appeared to be associated with a recurrence rate with borderline significance (P = 0.055).

Conclusions

Our findings indicate that the presence of SC in PTC, regardless of the proportion, is associated with adverse clinical parameters and a shorter DFS.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.